Look at alternant therapies that are not average CYP3A inducers during therapy with mitapivat. If not able to avoid coadministration, keep an eye on Hb and titrate outside of fifty mg BID, if necessary, but usually do not exceed mitapivat dose of one hundred mg BID. .pentobarbital will decrease the level or influence of buprenorphine subdermal impl